DEFINITIVE PROXY STATEMENTS

Company

RELMADA THERAPEUTICS, INC.

Filed

November 17, 2014

Period of Report

December 18, 2014

Accession Number

0001213900-14-008355

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →